Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
470.60    0.60 (0.13%)
Bid:
469.80
Ask:
470.20
Spread: 0.40 (0.085%)
Market Cap: £2.43b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

Share Buyback Programme

17 Nov 2025 07:00

RNS Number : 6728H
QinetiQ Group plc
17 November 2025
Β 

News release

QinetiQ Group plc

Share Buyback Programme

17 November 2025 - QinetiQ Group plc ("QinetiQ" or the "Group") confirms the completion by Numis Securities Limited ("Deutsche Numis") of the latest Β£50 million tranche of its share buyback programme, as announced on 5 June 2025. This was the first tranche of the Β£200m extension to its share buyback programme that was announced by QinetiQ on 17 March 2025, for execution over the following two years (the "Programme").

QinetiQ has today entered into an agreement with Deutsche Numis to execute the second tranche of the Β£200 million Programme, with a maximum aggregate value of up to Β£50 million (the "Second Tranche"). Under the Second Tranche, which is expected to complete by no later than 31 March 2026, Deutsche Numis will make trading decisions independently of QinetiQ in accordance with certain pre-set parameters. The Second Tranche will be effected under the authority granted by shareholders at QinetiQ's Annual General Meeting held on 17 July 2025 (the "2025 Authority"). The maximum remaining number of shares that may be repurchased pursuant to the 2025 Authority is 47,227,575 Ordinary Shares.

Any purchases under the Programme will be carried out on the London Stock Exchange and any other UK recognised investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with the Buyback Authority, Chapter 12 of the UK Financial Conduct Authority's Listing Rules, and Regulation (EU) No 596/2014 and Commission Delegated Regulation (EU) No 2016/1052 (both as they form part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018), including where relevant pursuant to the UK Market Abuse (Amendment) (EU Exit) Regulations 2019.

Any Ordinary Shares purchased pursuant to the Programme will be cancelled, and the number of Ordinary Shares in issue reduced accordingly.

About QinetiQ

QinetiQ is an integrated global defence and security company focused on mission-led innovation. QinetiQ employs circa 8,000 highly-skilled people, committed to creating new ways of protecting what matters most; testing technologies, systems, and processes to make sure they meet operational needs; and enabling customers to deploy new and enhanced capabilities with the assurance they will deliver the performance required.

For further information please contact:

Stephen Lamacraft, Interim Group Investor Relations Director:

+44 (0) 7471 885817

Stephanie Mann, Group Head of Media Relations:

+44 (0) 7770 720268

James Field, Company Secretary:

+44 (0) 7841 662957

Β 

QinetiQ Group plc LEI: 213800S8OBDOZMCMUW34

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCBIBRTMTMBBPA
Date   Source Headline
26th Feb 20183:31 pmRNSHolding(s) in Company
23rd Feb 20184:10 pmRNSHolding(s) in Company
15th Feb 20182:46 pmRNSHolding(s) in Company
12th Feb 20183:44 pmRNSHolding(s) in Company
12th Feb 20181:05 pmRNSDirector/PDMR Shareholding
12th Feb 201812:55 pmRNSDirector/PDMR Shareholding
9th Feb 20183:01 pmRNSDirector/PDMR Shareholding
8th Feb 20184:18 pmRNSHolding(s) in Company
8th Feb 20187:00 amRNSThird Quarter Trading Update
22nd Jan 20183:55 pmRNSHolding(s) in Company
10th Jan 201811:08 amRNSDirector/PDMR Shareholding
12th Dec 20173:55 pmRNSDirector/PDMR Shareholding
6th Dec 201712:42 pmRNSHolding(s) in Company
20th Nov 201712:25 pmRNSDirector/PDMR Shareholding
20th Nov 201710:59 amRNSDirector/PDMR Shareholding
20th Nov 201710:53 amRNSDirector/PDMR Shareholding
16th Nov 20177:00 amRNSInterim Results
10th Nov 20173:57 pmRNSDirector/PDMR Shareholding
1st Nov 20178:19 amRNSBlock listing Interim Review
18th Oct 20174:46 pmRNSHolding(s) in Company
10th Oct 20174:03 pmRNSHolding(s) in Company
10th Oct 201712:39 pmRNSDirector/PDMR Shareholding
6th Oct 20174:35 pmRNSHolding(s) in Company
29th Sep 20177:00 amRNSPre-Close Trading Statement
22nd Sep 20178:08 amRNSDirector/PDMR Shareholding
12th Sep 20172:08 pmRNSDirector/PDMR Shareholding
8th Sep 201710:43 amRNSDirector/PDMR Shareholding
5th Sep 20171:51 pmRNSHolding(s) in Company
4th Sep 20171:02 pmRNSDirector/PDMR Shareholding
4th Sep 201710:27 amRNSHolding(s) in Company
23rd Aug 201712:02 pmRNSHolding(s) in Company
22nd Aug 20174:19 pmRNSHolding(s) in Company
14th Aug 20173:52 pmRNSDirector/PDMR Shareholding
26th Jul 201712:23 pmRNSDirector/PDMR Shareholding
25th Jul 20173:43 pmRNSDirector/PDMR Shareholding
25th Jul 20179:41 amRNSDirector/PDMR Shareholding
24th Jul 20175:09 pmRNSDirector/PDMR Shareholding
24th Jul 20172:31 pmRNSDirector/PDMR Shareholding
21st Jul 201711:18 amRNSDirector/PDMR Shareholding
19th Jul 20174:05 pmRNSAGM Statement
19th Jul 20177:00 amRNSFirst Quarter Trading Update
13th Jul 20173:30 pmRNSDirector/PDMR Shareholding
11th Jul 20174:15 pmRNSDirector/PDMR Shareholding
7th Jul 20174:13 pmRNSAnnual Financial Report
23rd Jun 20179:40 amRNSDirector/PDMR Shareholding
21st Jun 20175:08 pmRNSDirector/PDMR Shareholding
13th Jun 20173:55 pmRNSAnnual Financial Report
12th Jun 20172:56 pmRNSDirector/PDMR Shareholding
25th May 20177:00 amRNSFull Year Results 2017
10th May 20174:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.